United States of America, ex rel, et al v. Novartis Pharmaceuticals Corporation
Case Number:
1:11-cv-08196
Court:
Nature of Suit:
Other Statutes: False Claims Act
Judge:
Firms
- Arnold & Porter
- Cravath Swaine
- Latham & Watkins
- Quinn Emanuel
- Selendy Gay
- Susman Godfrey
- Vogel Slade
- Williams & Connolly
Companies
Government Agencies
Sectors & Industries:
-
January 07, 2015
CVS Gets FCA Claims Of Novartis Kickbacks Trimmed
A New York federal judge on Tuesday partially dismissed claims against CVS Caremark Corp. and other pharmacies, in a whistleblower False Claims Act suit alleging they accepted kickbacks from Novartis Pharmaceuticals Corp.
-
September 30, 2014
Novartis' FCA Suit Discovery Request Slammed By States
California, New York, New Jersey and eight other states on Monday challenged Novartis Pharmaceutical Corp.'s bid for information on their medication adherence programs, saying the information is irrelevant to a whistleblower suit accusing Novartis of paying kickbacks to pharmacies.
-
September 11, 2014
Novartis Whistleblower Trims FCA Claims Against CVS
A whistleblower alleging Novartis Pharmaceuticals Corp. gave kickbacks to CVS Caremark Corp. and other pharmacies to induce them to push the company's drugs on Thursday shed some claims related to CVS' alleged involvement in the scheme, a day after a New York federal judge rejected his request for time.
-
September 05, 2014
Novartis Can't Escape FCA Drug Kickback Suit
A New York federal judge Thursday denied Novartis Pharmaceuticals Corp.’s attempt to escape a whistleblower suit over alleged kickbacks from two of the company’s drugs, letting the government pursue most of its allegations but threatening to reject its pre-Obamacare state Medicaid claims.
-
August 08, 2014
Novartis Gets Whistleblower Kickback Suit Pared
A New York federal judge on Thursday trimmed a whistleblower suit over an alleged kickback scheme involving pharmacies that pushed drugs from Novartis Pharmaceuticals Corp., keeping alive certain False Claims Act allegations and state law claims but tossing Medicaid false certification claims brought under the Anti-Kickback Statute.
-
July 07, 2014
Novartis Says Gov't Can't Prove Kickbacks Influenced Docs
Novartis Pharmaceuticals Corp. has told a New York federal judge to reject the federal government's argument that it properly pled False Claims Act violations in a whistleblower suit over an alleged kickback scheme with three pharmacies to push Novartis drugs, saying the government couldn't show the payments influenced physicians.
-
June 30, 2014
Government Says Novartis Can't Escape FCA Kickback Suit
Federal prosecutors urged the New York Southern District Court not to dismiss False Claims Act complaints against Novartis Pharmaceuticals Corp. on Friday, saying that the government doesn't need to plead a "but for" connection between the pharmaceutical's alleged kickback scheme and the law's falsity standard.
-
June 26, 2014
Surviving FCA Claims In Novartis Kickback Row To Stay Put
A New York federal judge on Thursday refused to reconsider whether he should toss several state and reverse False Claims Act accusations against pharmacies that allegedly received kickbacks from Novartis Pharmaceuticals Corp. for pushing its drugs, criticizing the pharmacies for raising new arguments.
-
June 16, 2014
Novartis Seeks Dismissal Of FCA Kickback Claims
Novartis Pharmaceuticals Corp. asked a New York federal judge on Friday to chuck complaints accusing it of violating the False Claims Act by paying kickbacks to pharmacies, arguing that a whistleblower and the U.S. government failed to allege that the payments influenced physicians.
-
June 11, 2014
Novartis Gets FCA Kickback Suit Pared Down
A New York federal judge on Tuesday pared down a whistleblower False Claims Act lawsuit against Novartis Pharmaceuticals Corp. and several specialty pharmacies over an alleged kickback scheme to push Novartis drugs, saying several of the allegations were "vague and unhelpful."
- ← Previous
- 1
- 2
- 3
- 4
- Next →